Nevro PE Ratio 2013-2023 | NVRO
Current and historical p/e ratio for Nevro (NVRO) from 2013 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nevro PE ratio as of November 28, 2023 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Nevro PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2023-11-29 | 16.76 | 0.00 | |
| 2023-09-30 | 19.22 | $-2.86 | 0.00 |
| 2023-06-30 | 25.42 | $0.01 | 2542.00 |
| 2023-03-31 | 36.15 | $-0.01 | 0.00 |
| 2022-12-31 | 39.60 | $-0.01 | 0.00 |
| 2022-09-30 | 46.60 | $-0.33 | 0.00 |
| 2022-06-30 | 43.83 | $-3.99 | 0.00 |
| 2022-03-31 | 72.33 | $-3.90 | 0.00 |
| 2021-12-31 | 81.07 | $-3.77 | 0.00 |
| 2021-09-30 | 116.38 | $-3.12 | 0.00 |
| 2021-06-30 | 165.79 | $-1.97 | 0.00 |
| 2021-03-31 | 139.50 | $-2.56 | 0.00 |
| 2020-12-31 | 173.10 | $-2.49 | 0.00 |
| 2020-09-30 | 139.30 | $-2.72 | 0.00 |
| 2020-06-30 | 119.47 | $-3.01 | 0.00 |
| 2020-03-31 | 99.98 | $-2.71 | 0.00 |
| 2019-12-31 | 117.54 | $-3.38 | 0.00 |
| 2019-09-30 | 85.97 | $-3.26 | 0.00 |
| 2019-06-30 | 64.83 | $-3.05 | 0.00 |
| 2019-03-31 | 62.51 | $-2.49 | 0.00 |
| 2018-12-31 | 38.89 | $-1.63 | 0.00 |
| 2018-09-30 | 57.00 | $-1.46 | 0.00 |
| 2018-06-30 | 79.85 | $-1.30 | 0.00 |
| 2018-03-31 | 86.67 | $-1.35 | 0.00 |
| 2017-12-31 | 69.04 | $-1.26 | 0.00 |
| 2017-09-30 | 90.88 | $-1.45 | 0.00 |
| 2017-06-30 | 74.43 | $-1.38 | 0.00 |
| 2017-03-31 | 93.70 | $-1.29 | 0.00 |
| 2016-12-31 | 72.66 | $-1.12 | 0.00 |
| 2016-09-30 | 104.39 | $-1.29 | 0.00 |
| 2016-06-30 | 73.76 | $-1.85 | 0.00 |
| 2016-03-31 | 56.26 | $-2.31 | 0.00 |
| 2015-12-31 | 67.51 | $-2.55 | 0.00 |
| 2015-09-30 | 46.39 | $-2.63 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.600B | $0.406B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $181.220B | 22.05 |
| Intuitive Surgical (ISRG) | United States | $109.614B | 73.26 |
| DexCom (DXCM) | United States | $42.099B | 80.71 |
| Edwards Lifesciences (EW) | United States | $40.751B | 26.77 |
| IDEXX Laboratories (IDXX) | United States | $39.278B | 48.26 |
| IQVIA Holdings (IQV) | United States | $37.465B | 22.36 |
| Alcon (ALC) | Switzerland | $35.104B | 28.82 |
| STERIS (STE) | Ireland | $19.740B | 23.93 |
| Hologic (HOLX) | United States | $17.611B | 18.20 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.183B | 0.00 |
| Waters (WAT) | United States | $15.428B | 21.80 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.508B | 14.53 |
| Sysmex ADR (SSMXY) | Japan | $10.978B | 32.31 |
| Teleflex (TFX) | United States | $10.091B | 15.72 |
| Penumbra (PEN) | United States | $9.088B | 158.02 |
| ShockWave Medical (SWAV) | United States | $6.457B | 27.26 |
| Globus Medical (GMED) | United States | $6.253B | 19.56 |
| Abcam (ABCM) | United Kingdom | $5.484B | 0.00 |
| Masimo (MASI) | United States | $5.004B | 27.53 |
| Inari Medical (NARI) | United States | $3.357B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $3.180B | 24.38 |
| Glaukos (GKOS) | United States | $3.119B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $3.025B | 12.29 |
| Integer Holdings (ITGR) | United States | $2.988B | 20.42 |
| LivaNova (LIVN) | United Kingdom | $2.524B | 17.04 |
| Pacific Biosciences Of California (PACB) | United States | $2.295B | 0.00 |
| TransMedics (TMDX) | United States | $2.280B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.179B | 18.16 |
| Veracyte (VCYT) | United States | $1.902B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.668B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.550B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.201B | 0.00 |
| OPKO Health (OPK) | United States | $1.144B | 0.00 |
| RxSight (RXST) | United States | $1.012B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.994B | 15.19 |
| Paragon 28 (FNA) | United States | $0.858B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.744B | 0.00 |
| SiBone (SIBN) | United States | $0.731B | 0.00 |
| Artivion (AORT) | United States | $0.580B | 70.60 |
| IRadimed (IRMD) | United States | $0.541B | 33.28 |
| Treace Medical Concepts (TMCI) | United States | $0.530B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.481B | 14.99 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.398B | 0.00 |
| CVRx (CVRX) | United States | $0.379B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.344B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.323B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.297B | 10.90 |
| AngioDynamics (ANGO) | United States | $0.274B | 0.00 |
| Accuray (ARAY) | United States | $0.263B | 0.00 |
| AxoGen (AXGN) | United States | $0.260B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.254B | 14.76 |
| NeuroPace (NPCE) | United States | $0.229B | 0.00 |
| 908 Devices (MASS) | United States | $0.217B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.201B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.166B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.143B | 0.00 |
| Inogen (INGN) | United States | $0.135B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.123B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.111B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.093B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.076B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | Israel | $0.060B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
| Eargo (EAR) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.044B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Neuronetics (STIM) | United States | $0.039B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.030B | 0.00 |
| PAVmed (PAVM) | United States | $0.026B | 0.00 |
| LENSAR (LNSR) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Spectral AI (MDAI) | United States | $0.018B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Envoy Medical (COCH) | United States | $0.015B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PetVivo Holdings (PETV) | United States | $0.010B | 0.00 |
| Sientra (SIEN) | United States | $0.010B | 0.00 |
| Venus Concept (VERO) | Canada | $0.009B | 0.00 |
| Nemaura Medical (NMRD) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
